GDC-0134

N/A

Report date: 2025/03/16 20:00:05

Base Information

Drug NameGDC-0134

Drug Alias NameGDC-0134RG-6000

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMitogen-activated protein kinase kinase kinase 12 inhibitorsNeurons modulators

TargetsMitogen-activated protein kinase kinase kinase 12

Therapy Area/IndicationsAmyotrophic Lateral Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited StatesNetherlands +[4]

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGenentech Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesGenentech Inc

Active IndicationsN/A

Inactive IndicationsAmyotrophic Lateral Sclerosis

ATC CodeN/A